Abnormal changes in NKT cells, the IGF-1 axis, and liver pathology in an animal model of ALS

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Finkelstein, Arseny ^a   Kunis, Gilad ^a   Seksenyan, Akop ^b   Ronen, Ayal ^a   Berkutzki, Tamara ^a   Azoulay, David ^b,c   Koronyo Hamaoui, Maya ^b   Schwartz, Michal ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; SOMATOMEDIN C; SUPEROXIDE DISMUTASE; PRIMER DNA;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; LIVER; LYMPHOID ORGAN; MOUSE; NATURAL KILLER CELL; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SPINAL CORD; T LYMPHOCYTE; WILD TYPE; ANIMAL; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; SPLEEN;

ANIMALIA; MUS;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BASE SEQUENCE; DISEASE MODELS, ANIMAL; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR I; KILLER CELLS, NATURAL; LIVER; MICE; REAL-TIME POLYMERASE CHAIN REACTION; SPINAL CORD; SPLEEN; SUPEROXIDE DISMUTASE; T-LYMPHOCYTES;

EID: 79960987739     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022374     Document Type: Article

References (75)

1. Rosen DR, Siddique T, Patterson D, lewicz DA, Sapp P, et al. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59-62.
2. Boillee S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, et al. (2006) Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312: 1389-1392.
3. Xiao Q, Zhao W, Beers DR, Yen AA, Xie W, et al. (2007) Mutant SOD1(G93A) microglia are more neurotoxic relative to wild-type microglia. J Neurochem 102: 2008-2019.
4. Gowing G, Philips T, Van Wijmeersch B, Audet JN, Dewil M, et al. (2008) Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase. J Neurosci 28: 10234-10244.
5. Butovsky O, Koronyo-Hamaoui M, Kunis G, Ophir E, Landa G, et al. (2006) Glatiramer acetate hts against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proc Natl Acad Sci U S A 103: 11784-11789.
6. Hauben E, Agranov E, Gothilf A, Nevo U, Cohen A, et al. (2001) Posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune disease. J Clin Invest 108: 591-599.
7. Kipnis J, Mizrahi T, Hauben E, Shaked I, Shevach E, et al. (2002) Neuroprotective autoimmunity: naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system. Proc Natl Acad Sci U S A 99: 15620-15625.
8. Moalem G, Leibowitz-Amit R, Yoles E, Mor F, Cohen IR, et al. (1999) Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med 5: 49-55.
9. Frenkel D, Huang Z, Maron R, Koldzic DN, Moskowitz MA, et al. (2005) Neuroprotection by IL-10-producing MOG CD4+ T cells following ischemic stroke. J Neurol Sci 233: 125-132.
10. Banerjee R, Mosley RL, Reynolds AD, Dhar A, Jackson-Lewis V, et al. (2008) Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice. PLoS ONE 3: e2740.
11. Beers DR, Henkel JS, Zhao W, Wang J, Appel SH, (2008) CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS. Proc Natl Acad Sci U S A 105: 15558-15563.
12. Chiu IM, Chen A, Zheng Y, Kosaras B, Tsiftsoglou SA, et al. (2008) T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS. Proc Natl Acad Sci U S A 105: 17913-17918.
13. Seksenyan A, Ron-Harel N, Azoulay D, Cahalon L, Cardon M, et al. Thymic involution, a co-morbidity factor in amyotrophic lateral sclerosis. J Cell Mol Med 4: 2470-2482.
14. Dolcetti L, Marigo I, Mantelli B, Peranzoni E, Zanovello P, et al. (2008) Myeloid-derived suppressor cell role in tumor-related inflammation. Cancer Lett 267: 216-225.
15. Hammond KJ, Kronenberg M, (2003) Natural killer T cells: natural or unnatural regulators of autoimmunity? Curr Opin Immunol 15: 683-689.
16. Pomie C, Menager-Marcq I, van Meerwijk JP, (2008) Murine CD8+ regulatory T lymphocytes: the new era. Hum Immunol 69: 708-714.
17. La Cava A, Van Kaer L, Fu Dong S, (2006) CD4+CD25+ Tregs and NKT cells: regulators regulating regulators. Trends Immunol 27: 322-327.
18. Bendelac A, Lantz O, Quimby ME, Yewdell JW, Bennink JR, et al. (1995) CD1 recognition by mouse NK1+ T lymphocytes. Science 268: 863-865.
19. Kawamura T, Takeda K, Kaneda H, Matsumoto H, Hayakawa Y, et al. (2009) NKG2A inhibits invariant NKT cell activation in hepatic injury. J Immunol 182: 250-258.
20. Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, et al. (1997) CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278: 1626-1629.
21. Liu Y, Goff RD, Zhou D, Mattner J, Sullivan BA, et al. (2006) A modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells. J Immunol Methods 312: 34-39.
22. Halder RC, Jahng A, Maricic I, Kumar V, (2007) Mini review: immune response to myelin-derived sulfatide and CNS-demyelination. Neurochem Res 32: 257-262.
23. van der Vliet HJ, von Blomberg BM, Nishi N, Reijm M, Voskuyl AE, et al. (2001) Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin Immunol 100: 144-148.
24. Grajewski RS, Hansen AM, Agarwal RK, Kronenberg M, Sidobre S, et al. (2008) Activation of invariant NKT cells ameliorates experimental ocular autoimmunity by a mechanism involving innate IFN-gamma production and dampening of the adaptive Th1 and Th17 responses. J Immunol 181: 4791-4797.
25. Beaudoin L, Laloux V, Novak J, Lucas B, Lehuen A, (2002) NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic beta cells. Immunity 17: 725-736.
26. Mars LT, Laloux V, Goude K, Desbois S, Saoudi A, et al. (2002) Cutting edge: V alpha 14-J alpha 281 NKT cells naturally regulate experimental autoimmune encephalomyelitis in nonobese diabetic mice. J Immunol 168: 6007-6011.
27. Schwartz M, Ziv Y, (2008) Immunity to self and self-maintenance: what can tumor immunology teach us about ALS and Alzheimer's disease? Trends Pharmacol Sci 29: 287-293.
28. Serizawa I, Koezuka Y, Amao H, Saito TR, Takahashi KW, (2000) Functional natural killer T cells in experimental mouse strains, including NK1.1- strains. Exp Anim 49: 171-180.
29. Kaspar BK, Llado J, Sherkat N, Rothstein JD, Gage FH, (2003) Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 301: 839-842.
30. Zimmermann EM, Li L, Hoyt EC, Pucilowska JB, Lichtman S, et al. (2000) Cell-specific localization of insulin-like growth factor binding protein mRNAs in rat liver. Am J Physiol Gastrointest Liver Physiol 278: G447-457.
31. Schwartz M, Shechter R, Systemic inflammatory cells ht off neurodegenerative disease. Nat Rev Neurol.
32. Parekh VV, Wilson MT, Olivares-Villagomez D, Singh AK, Wu L, et al. (2005) Glycolipid antigen induces long-term natural killer T cell anergy in mice. J Clin Invest 115: 2572-2583.
33. Yamanaka K, Chun SJ, Boillee S, Fujimori-Tonou N, Yamashita H, et al. (2008) Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 11: 251-253.
34. Beers DR, Henkel JS, Xiao Q, Zhao W, Wang J, et al. (2006) Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 103: 16021-16026.
35. Nagai M, Re DB, Nagata T, Chalazonitis A, Jessell TM, et al. (2007) Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci 10: 615-622.
36. Uldrich AP, Crowe NY, Kyparissoudis K, Pellicci DG, Zhan Y, et al. (2005) NKT cell stimulation with glycolipid antigen in vivo: costimulation-dependent expansion, Bim-dependent contraction, and hyporesponsiveness to further antigenic challenge. J Immunol 175: 3092-3101.
37. Dawson G, Stefansson K, (1984) Gangliosides of human spinal cord: aberrant composition of cords from patients with amyotrophic lateral sclerosis. J Neurosci Res 12: 213-220.
38. Kundu SK, Harati Y, Misra LK, (1984) Sialosylglobotetraosylceramide: a marker for amyotropic lateral sclerosis. Biochem Biophys Res Commun 118: 82-89.
39. Rapport MM, Donnenfeld H, Brunner W, Hungund B, Bartfeld H, (1985) Ganglioside patterns in amyotrophic lateral sclerosis brain regions. Ann Neurol 18: 60-67.
40. Dupuis L, Oudart H, Rene F, Gonzalez de Aguilar JL, Loeffler JP, (2004) Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci U S A 101: 11159-11164.
41. Dupuis L, Corcia P, Fergani A, Gonzalez De Aguilar JL, Bonnefont-Rousselot D, et al. (2008) Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology 70: 1004-1009.
42. Mars LT, Gautron AS, Novak J, Beaudoin L, Diana J, et al. (2008) Invariant NKT cells regulate experimental autoimmune encephalomyelitis and infiltrate the central nervous system in a CD1d-independent manner. J Immunol 181: 2321-2329.
43. Henkel JS, Engelhardt JI, Siklos L, Simpson EP, Kim SH, et al. (2004) Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol 55: 221-235.
44. Graves MC, Fiala M, Dinglasan LA, Liu NQ, Sayre J, et al. (2004) Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells. Amyotroph Lateral Scler Other Motor Neuron Disord 5: 213-219.
45. Yoles E, Hauben E, Palgi O, Agranov E, Gothilf A, et al. (2001) Protective autoimmunity is a physiological response to CNS trauma. J Neurosci 21: 3740-3748.
46. Shaked I, Tchoresh D, Gersner R, Meiri G, Mordechai S, et al. (2005) Protective autoimmunity: interferon-gamma enables microglia to remove glutamate without evoking inflammatory mediators. J Neurochem 92: 997-1009.
47. Hickman SE, Allison EK, El Khoury J, (2008) Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J Neurosci 28: 8354-8360.
48. Kipnis J, Yoles E, Porat Z, Cohen A, Mor F, et al. (2000) T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies. Proc Natl Acad Sci U S A 97: 7446-7451.
49. Bakalash S, Kessler A, Mizrahi T, Nussenblatt R, Schwartz M, (2003) Antigenic specificity of immunoprotective therapeutic vaccination for glaucoma. Invest Ophthalmol Vis Sci 44: 3374-3381.
50. Frenkel D, Maron R, Burt DS, Weiner HL, (2005) Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears beta-amyloid in a mouse model of Alzheimer disease. J Clin Invest 115: 2423-2433.
51. Angelov DN, Waibel S, Guntinas-Lichius O, Lenzen M, Neiss WF, et al. (2003) Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 100: 4790-4795.
52. Habisch HJ, Schwalenstocker B, Danzeisen R, Neuhaus O, Hartung HP, et al. (2007) Limited effects of glatiramer acetate in the high-copy number hSOD1-G93A mouse model of ALS. Exp Neurol 206: 288-295.
53. Haenggeli C, Julien JP, Mosley RL, Perez N, Dhar A, et al. (2007) Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS. Neurobiol Dis 26: 146-152.
54. Schwartz M, Bukshpan S, Kunis G, (2008) Application of glatiramer acetate to neurodegenerative diseases beyond multiple sclerosis: the need for disease-specific approaches. BioDrugs 22: 293-299.
55. Di Giorgio FP, Carrasco MA, Siao MC, Maniatis T, Eggan K, (2007) Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat Neurosci 10: 608-614.
56. Sjogren K, Liu JL, Blad K, Skrtic S, Vidal O, et al. (1999) Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci U S A 96: 7088-7092.
57. Desbois-Mouthon C, Wendum D, Cadoret A, Rey C, Leneuve P, et al. (2006) Hepatocyte proliferation during liver regeneration is impaired in mice with liver-specific IGF-1R knockout. FASEB J 20: 773-775.
58. Jones JI, Clemmons DR, (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16: 3-34.
59. Ricort JM, (2004) Insulin-like growth factor binding protein (IGFBP) signalling. Growth Horm IGF Res 14: 277-286.
60. Leu JI, Crissey MA, Taub R, (2003) Massive hepatic apoptosis associated with TGF-beta1 activation after Fas ligand treatment of IGF binding protein-1-deficient mice. J Clin Invest 111: 129-139.
61. Carro E, Spuch C, Trejo JL, Antequera D, Torres-Aleman I, (2005) Choroid plexus megalin is involved in neuroprotection by serum insulin-like growth factor I. J Neurosci 25: 10884-10893.
62. Masui Y, Mozai T, Kakehi K, (1985) Functional and morphometric study of the liver in motor neuron disease. J Neurol 232: 15-19.
63. Harraz MM, Marden JJ, Zhou W, Zhang Y, Williams A, et al. (2008) SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model. J Clin Invest 118: 659-670.
64. Yamada Y, Kirillova I, Peschon JJ, Fausto N, (1997) Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci U S A 94: 1441-1446.
65. Ito H, Ando K, Nakayama T, Taniguchi M, Ezaki T, et al. (2003) Role of Valpha 14 NKT cells in the development of impaired liver regeneration in vivo. Hepatology 38: 1116-1124.
66. Dal Canto MC, Gurney ME, (1994) Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am J Pathol 145: 1271-1279.
67. Kong J, Xu Z, (1998) Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J Neurosci 18: 3241-3250.
68. Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, et al. (1995) An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14: 1105-1116.
69. Bruijn LI, Miller TM, Cleveland DW, (2004) Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 27: 723-749.
70. Renukaradhya GJ, Khan MA, Vieira M, Du W, Gervay-Hague J, et al. (2008) Type I NKT cells protect (and type II NKT cells suppress) the host's innate antitumor immune response to a B-cell lymphoma. Blood 111: 5637-5645.
71. Roelofs-Haarhuis K, Wu X, Gleichmann E, (2004) Oral tolerance to nickel requires CD4+ invariant NKT cells for the infectious spread of tolerance and the induction of specific regulatory T cells. J Immunol 173: 1043-1050.
72. Santodomingo-Garzon T, Han J, Le T, Yang Y, Swain MG, (2008) Natural killer T cells regulate the homing of chemokine CXC receptor 3-positive regulatory T cells to the liver in mice. Hepatology.
73. Deng ZB, Liu Y, Liu C, Xiang X, Wang J, et al. (2009) Immature myeloid cells induced by a high-fat diet contribute to liver inflammation. Hepatology 50: 1412-1420.
74. Butovsky O, Kunis G, Koronyo-Hamaoui M, Schwartz M, (2007) Selective ablation of bone marrow-derived dendritic cells increases amyloid plaques in a mouse Alzheimer's disease model. Eur J Neurosci 26: 413-416.
75. Kang J, Rivest S, (2007) MyD88-deficient bone marrow cells accelerate onset and reduce survival in a mouse model of amyotrophic lateral sclerosis. J Cell Biol 179: 1219-1230.